AU2001250530A1 - Treatment of conditions of the central nervous system using mycobacteria - Google Patents

Treatment of conditions of the central nervous system using mycobacteria

Info

Publication number
AU2001250530A1
AU2001250530A1 AU2001250530A AU5053001A AU2001250530A1 AU 2001250530 A1 AU2001250530 A1 AU 2001250530A1 AU 2001250530 A AU2001250530 A AU 2001250530A AU 5053001 A AU5053001 A AU 5053001A AU 2001250530 A1 AU2001250530 A1 AU 2001250530A1
Authority
AU
Australia
Prior art keywords
mycobacteria
treatment
conditions
nervous system
central nervous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001250530A
Inventor
Stafford Louis Lightman
Christopher Alan Lowry
Graham Arthur Will Rook
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Silence Therapeutics PLC
Original Assignee
Stanford Rook Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanford Rook Ltd filed Critical Stanford Rook Ltd
Publication of AU2001250530A1 publication Critical patent/AU2001250530A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2001250530A 2000-04-28 2001-04-27 Treatment of conditions of the central nervous system using mycobacteria Abandoned AU2001250530A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0010496 2000-04-28
GBGB0010496.8A GB0010496D0 (en) 2000-04-28 2000-04-28 Treatment of conditions of the central nervous system
PCT/GB2001/001867 WO2001082939A1 (en) 2000-04-28 2001-04-27 Treatment of conditions of the central nervous system using mycobacteria

Publications (1)

Publication Number Publication Date
AU2001250530A1 true AU2001250530A1 (en) 2001-11-12

Family

ID=9890758

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001250530A Abandoned AU2001250530A1 (en) 2000-04-28 2001-04-27 Treatment of conditions of the central nervous system using mycobacteria

Country Status (7)

Country Link
US (1) US20030170275A1 (en)
EP (1) EP1276487A1 (en)
JP (1) JP2003531859A (en)
AU (1) AU2001250530A1 (en)
CA (1) CA2407136A1 (en)
GB (1) GB0010496D0 (en)
WO (1) WO2001082939A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201216800D0 (en) 2012-09-20 2012-11-07 Immodulon Therapeutics Ltd Novel use
US11077179B2 (en) 2017-08-10 2021-08-03 Epicgenetics, Inc. Method for treating fibromyalgia and chronic fatigue syndrome

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9203814D0 (en) * 1992-02-21 1992-04-08 Univ London Treatment of long term auto-immune conditions
GB9505658D0 (en) * 1995-03-21 1995-05-10 Univ London Hormone and growth factor mimetics
GB9903539D0 (en) * 1999-02-16 1999-04-07 Stanford Rook Ltd Therapy using M.Vaccae

Also Published As

Publication number Publication date
CA2407136A1 (en) 2001-11-08
EP1276487A1 (en) 2003-01-22
WO2001082939A1 (en) 2001-11-08
JP2003531859A (en) 2003-10-28
US20030170275A1 (en) 2003-09-11
GB0010496D0 (en) 2000-06-14

Similar Documents

Publication Publication Date Title
AU2002211612A1 (en) Methods for the treatment of a traumatic central nervous system injury
AU2002356505A1 (en) Wastewater treatment system
AU2001257342A1 (en) Treatment well tiltmeter system
AU2001247474A1 (en) Compounds for the treatment of psychiatric or substance abuse disorders
AU2002212226A1 (en) Use of indole derivatives for treating illnesses of the central nervous system
IL155589A0 (en) Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
HK1051690A1 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidederivatives for the treatment of pain.
AU6910600A (en) Methods for the treatment of mental disorders
AU2001239858A1 (en) Wastewater treatment process
WO2001098279A3 (en) Bis-arylsulfones
AUPR074500A0 (en) Treatment of t cell disorders
AU2001260834A1 (en) The treatment of herpes
AU2586402A (en) Methods of improving central nervous system functioning
HK1051692A1 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain.
AU2002227895A1 (en) Sulphonamides for the treatment of central nervous system diseases
AU5509099A (en) Pyridinones for the treatment of sexual dysfunction
AU2001244834A1 (en) Novel strain for decomposing tmah, and method of wastewater treatment using the same
AU7652400A (en) Novel combination for the treatment of sexual dysfunction
AU2080201A (en) Treatment of addiction disorders
AU2001250530A1 (en) Treatment of conditions of the central nervous system using mycobacteria
AU3899100A (en) Treatment of hyperactivity disorders
GB9904773D0 (en) Culture of mycobacteria
AU2566201A (en) Compounds and methods for the treatment of pain
AU3753500A (en) Methods of treating fibrinogen-related disorders
AU2003202255A1 (en) Compositions for treatment of central nervous system neoplasms, and methods of making and using the same